CHRISTOPHER Y CHAI
CIK 1413823 · Chief Financial Officer · last filed 2026-05-14
CHRISTOPHER Y CHAI is a Chief Financial Officer who has filed 26 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for SRZNW, was dated May 14, 2026. Across all open-market trades the lifetime net is −$3.3M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
26
-$3.33M
Holdings By Company
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2025-05-15 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2020-09-28 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | −7,101 | -$710.1K | EDGAR |
| 2020-08-20 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$722.8K | EDGAR |
| 2020-05-21 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | −1,825 | -$471.3K | EDGAR |
| 2020-03-05 | Principia Biopharma Inc. (PRNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-20 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | −5,000 | -$486.7K | EDGAR |